Céline Dion is gearing up for her upcoming five-week residency in Paris, where she will be performing starting next month. In a recent interview with Harper’s Bazaar, the Canadian music icon shared insights into her battle with stiff person syndrome, a rare neurological autoimmune disorder she was diagnosed with in 2022 after experiencing symptoms for 17 years.
The debilitating pain associated with stiff person syndrome, which intensified in 2020, often left Dion struggling to walk and reliant on high doses of Valium for relief. This progressive disorder, affecting only a small fraction of the population, manifests through rigid muscles and painful spasms triggered by stress, loud noises, or sudden movements. While there is no definitive cause or approved treatment for the condition, various therapies can help manage its symptoms.
Prior to her diagnosis, Dion concealed the true extent of her suffering, attributing show cancellations to minor ailments like coughs or sinus infections. Feeling a sense of dishonesty towards her loyal supporters, she acknowledged their unwavering encouragement that enabled her to seek extensive treatment.
Following her diagnosis, Dion made the difficult decision to cancel all scheduled performances. Although she has not graced the stage since the 2024 Paris Olympics, she is poised to make a comeback in September.
Dion’s journey towards recovery includes a rigorous regimen comprising medication, physical therapy, vocal exercises, and immunotherapy. Additionally, she engages in 90-minute Pilates sessions thrice weekly and ballet classes twice a week to prepare for her forthcoming shows.
Described as constantly in motion and wary of stillness for fear of stiffness, Dion perceives her recovery and return to performing as a miraculous opportunity not to be taken for granted. Expressing a mix of strength, excitement, and nervousness, she eagerly anticipates her Paris residency, featuring 26 concerts scheduled from September 12 to May 29 the following year.